Clinical Trial

Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The investigators are studying whether treatment with a proton pump inhibitor called omeprazole reduces gastrointestinal bleeding in older adults taking blood thinners for a blood clot (venous thromboembolism). The purpose of this study, a pilot study or a feasibility study, is to test the study plan and determine whether enough participants will join a larger study and accept the study procedures.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-04-26; most recent amendment 2026-07-20.
Status change: Not Yet Recruiting → Recruiting 2025-07-28
Trial Details
NCT Number NCT06393868
Lead Sponsor Ottawa Hospital Research Institute
Conditions Venous Thromboembolism, Gastro Intestinal Bleeding, Blood Clot
Enrollment 360 participants
Start Date 2024-11-06
Primary Completion 2027-12 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-22